An adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics (Q36605779)
Jump to navigation
Jump to search
scientific article published on November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics |
scientific article published on November 2012 |
Statements
1 reference
An adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics (English)
1 reference
Mary Jane Geiger
1 reference
Zachary Skrivanek
1 reference
Brenda Gaydos
1 reference
Jenny Chien
1 reference
Scott Berry
1 reference
Donald Berry
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference